Move from Dialyze Direct’s Strategic Advisory Board, which he joined in 2019
BROOKLYN, N.Y.–January 12, 2022 –Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNF), is pleased to welcome Robert Aberman as Senior Vice President of Population Health. As the newest member of the company’s senior leadership team, Aberman will be responsible for growing relationships with healthcare systems, hospitals, payors, and other organizations focused on improving clinical and quality-of-life outcomes while reducing the cost of care for patients living with kidney disease. In addition, Aberman is engaged in Dialyze Direct’s industry-leading effort to improve the adoption of home hemodialysis among members of historically marginalized communities.
“Robert’s extensive knowledge of the healthcare services industry and experience working with growth companies make him an excellent fit for this critical role. I am confident that Robert’s wealth of talent and experience will enable him to play a significant role in enhancing patient care and achieving our ambitious growth plans in the year ahead and beyond,” said Chairman and CoFounder Henry Kauftheil. “I’m delighted to welcome Robert to the Dialyze Direct team.”
Aberman’s healthcare industry experience includes a nine-year tenure with Compassionate Care Hospice, which operated 53 locations in 22 states at the time of its acquisition by Amedisys in 2019. He most recently served as the company’s director of post-acute care payer relations, a role that entailed developing relationships and programs with insurance companies and health systems across the country. His previous roles at Compassionate Care Hospice included serving as New York City program director, in which he was responsible for overseeing hospice services in the city, and as director of business development.
“I was drawn to Dialyze Direct because not only does it have a reputation for delivering best-inclass, patient-focused treatment, it is also a true innovator. The improved standard of care the company has established is disrupting the industry in the best possible sense by changing more lives for the better every day,” said Aberman. “I look forward to helping the Dialyze Direct team to identify new and innovative ways to continually enhance the quality-of-care patients receive and the outcomes they achieve.”
Before transitioning into the healthcare field, Aberman spent more than a decade as a financial services executive at Jeffries & Company, Bear Stearns, Merrill Lynch and J.P. Morgan. He holds an MBA from Columbia University and a B.S. in economics from the Wharton School at the University of Pennsylvania.
Dialyze Direct, founded in 2015, is a leading kidney care innovation company that pioneers breakthrough solutions for patients suffering from kidney disease. With a mission to build the next generation of kidney care, Dialyze Direct leverages its leading nephrology specialists to evolve the treatment options nephrologists have at their disposal. Dialyze Direct pioneered significant changes to the existing treatment model for dialysis patients in skilled nursing facilities (SNFs), in which many of the most medically challenging subsets of dialysis patients reside and has grown to become the nation’s largest provider of home dialysis in the SNF setting. Dialyze Direct’s innovative staff-assisted home hemodialysis treatment model entails a gentler, personalized treatment plan comprised of meticulously crafted protocols designed tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations while substantially decreasing costs for payors. Dialyze Direct currently operates in13 states and is in the process of launching operations in additional states.
Zumado Public Relations
Nicholas Gaffney
415-732-7801
NEW YORK–(BUSINESS WIRE)–Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNF), announced today that it has acquired Renew Dialysis, a regional provider of on-site dialysis services in SNFs with eight locations in Ohio and one in Virginia. Renew Dialysis was co-founded by Cleveland-based Saber Healthcare Group, which is affiliated with more than 120 skilled nursing and assisted living facilities in seven states, and Nola McMullen, who serves as Renew’s Chief Operating Officer, to improve SNF patients’ well-being and comfort with the experience of on-site dialysis.
The acquisition solidifies Dialyze Direct’s position as the leading SNF dialysis provider in Ohio and expands its national footprint to Virginia. Dialyze Direct now provides services to residents of more than 130 SNFs across 13 states.
“Our forward-thinking approach to delivering compassionate on-site dialysis treatment to residents of skilled nursing facilities makes this transaction a natural fit as we continue to expand the Dialyze Direct footprint,” said Josh Rothenberg, President and Co-Founder of Dialyze Direct. “Our shared commitment to providing best-in-class patient care is the driving force behind the acquisition and we look forward to working together to improve patients’ lives.”
The transaction represents a strong strategic fit for Dialyze Direct and is expected to achieve operating synergies and cost efficiencies in the integration of the acquired business. Going forward, the parties plan to work together to bring Dialyze Direct’s unique model of on-site dialysis services to a significant number of additional facilities in several states.
“Renew Dialysis is a patient-focused provider and we decided that Dialyze Direct is the right partner to take our patient care model to the next level due to their leadership in the SNF home dialysis market, their extensive hospital and payor relationships and their national scale. This will benefit our patients and meet the unique needs of today’s underserved market,” said Nola McMullen, Renew’s Chief Operating Officer.
“We are confident that Renew Dialysis’ patients will receive the highest caliber of care from Dialyze Direct,” added Mike Demagall, Vice President of Population Health at Saber Healthcare Group. “We continually look for ways to enhance and improve the treatment provided to residents, and we believe Dialyze Direct is the best choice to provide our residents with superior on-site dialysis services.”
Dialyze Direct provides comprehensive, turn-key home dialysis solutions that allow patients with end-stage renal disease (ESRD) to take advantage of patient-centric home dialysis technologies with assistance and oversight by trained dialysis nurses and technicians. Dialyze Direct’s innovative care model is particularly well-suited to elderly “geriatric” patients with complex comorbidities, eliminating the expensive transportation and burdensome process associated with outpatient dialysis clinics. The company’s dedicated nurses, dieticians, social workers, and clinical support staff work in collaboration with each patient’s nephrologist to ensure the delivery of meticulously planned treatment customized for the patients’ specific needs, driving significantly improved outcomes and quality of life.
Founded in 2015, Dialyze Direct is a leading kidney care innovation company that seeks breakthrough solutions for patients suffering from kidney disease. With a mission to build the next generation of kidney care, Dialyze Direct leverages the deep experience of its leading nephrology specialists to develop new methods and technology to evolve the treatment options nephrologists have at their disposal. Dialyze Direct pioneered significant changes to the existing treatment model for dialysis patients in skilled nursing facilities, in which many of the most medically challenging subsets of dialysis patients reside, and the company has grown to become the nation’s largest provider of home dialysis in the skilled nursing facility setting. Dialyze Direct’s innovative staff-assisted home hemodialysis treatment model entails a gentler, personalized treatment plan comprised of meticulously crafted protocols and procedures that specifically tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations while substantially decreasing costs for payors. Dialyze Direct currently operates in Florida, Illinois, Indiana, Kentucky, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, Tennessee, Texas and now Virginia with new operations launching soon in additional states.
Established in 2001, Cleveland-based Saber Healthcare Group has grown from two skilled nursing facilities to more than 120 skilled nursing and assisted living facilities in seven states (Ohio, Indiana, Pennsylvania, Delaware, Virginia, North Carolina, and Florida). Saber’s “On the Cutting Edge of Healthcare” philosophy has spurred its growth and the company to implement greater healthcare knowledge and technologies to serve residents and facilities in better ways.
Zumado Public Relations
Nicholas Gaffney
415-732-7801
NEPTUNE, NJ, DECEMBER 21, 2021 – Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNF), announced today that it has expanded its footprint to Missouri and has increased its operations in Florida and New York. These new locations cap off a year of remarkable growth for Dialyze Direct.
“It’s exhilarating to reflect on the significant growth we’ve achieved in 2021, in terms of the thousands of individuals we provide a gentler, more dignified and more effective dialysis treatment by utilizing the NxStage dialysis machine,” said President and Co-Founder Josh Rothenberg. “Six years ago, we set out to reimagine the dialysis regimen for geriatric nursing home patients living with End Stage Renal Disease. We have successfully built an organization that offers a new model of care to SNFs onsite, that reduces the cost of sending their patients to other facilities for dialysis, reduces re-hospitalizations and risk of infection – and increases dialysis patients’ quality of life. In the year ahead, we will continue to work diligently toward our steadfast mission: to bring better dialysis, the Dialyze Direct home hemodialysis regimen, to as many people as we possibly can.”
Dialyze Direct, which established the superior standard of care in SNFs by offering a gentler and more patient-centric model of care, now provides services to thousands of SNF patients across 12 states including Florida, Illinois, Indiana, Kentucky, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, Tennessee, and Texas. The number of patients benefitting from the Dialyze Direct model of care increased by 15%, with Dialyze Direct also succeeding in substantial health care payor network expansion, allowing for more dialysis patients to be eligible to receive Dialyze Direct care.
“The Covid-19 pandemic has underscored how valuable it is for skilled nursing facilities to mitigate risk by treating dialysis patients onsite rather than transporting them to outside facilities. Not only do Dialyze Direct’s staff-assisted home hemodialysis programs keep everyone in nursing home communities safer, pandemic or not, patient outcomes are significantly improved,” said Dr. Allen Kaufman, Chief Medical Officer. “It’s thrilling to see how well patients respond to our model of care, from recovering more quickly following treatment to reducing the number of medications they require and, ultimately, living happier and healthier lives. In my 40 years as a nephrologist, I’ve never been more enthusiastic about the standard of care I’m able to help deliver to patients whose lives depend on it.”
Dialyze Direct, founded in 2016, is a leading kidney care innovation company that pioneers breakthrough solutions for patients suffering from kidney disease. With a mission to build the next generation of kidney care, Dialyze Direct works with the world’s preeminent nephrology talent to develop new methods and technology to evolve the treatment options nephrologists have at their disposal. The company’s initial focus is on skilled nursing facilities, in which many of the most medically challenging subsets of dialysis patients reside. Dialyze Direct’s innovative staff-assisted home hemodialysis treatment model entails a gentler, personalized treatment plan comprised of meticulously crafted protocols and procedures that specifically tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations while substantially decreasing costs for payors. Dialyze Direct currently operates in Florida, Illinois, Indiana, Kentucky, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, Tennessee, and Texas and is in the process of launching operations in additional states.
Zumado Public Relations
Nicholas Gaffney
415-732-7801
By Maggie Flynn | April 8, 2021. Find the full article here
For skilled nursing facilities, the ability to treat patients in place has far-reaching implications, perhaps most prominently in reducing unnecessary hospitalizations.
Usually that reduction is framed in terms of cost, with penalties for hospitals and SNFs alike if a patient returns to the acute care setting too soon. SNFs that perform well in preventing resident rehospitalizations can earn bonuses, for instance, through the Medicare Value-Based Purchasing (VBP) program.
But even though controversy exists around the effectiveness of that program, there are other benefits. Institutional special needs plans (I-SNPs), a Medicare Advantage program specifically for residents in long-term care facilities, have pointed to the clinical benefits of treating patients in place in any context, but particularly in times of major contagious illness where any interaction can be risky — and hospitals have sometimes been overwhelmed.
And for the residents themselves, treating in place prevents the hassle — and sometimes the trauma — of going to and from the SNF to a new setting. For some operators, dialysis services present an opportunity for SNFs to expand their ability to treat to patients in place — and find their footing in a post-COVID world.
Home hemodialysis in the skilled nursing setting would allow SNFs to avoid some of those rehospitalizations and improve patient outcomes, even before the pandemic, according to Jonathan Paull, chief compliance officer and general counsel at Dialyze Direct.
By offering this service, SNFs can attract new patients who might need it, in turn, improving their census; the operator SavaSeniorCare, for instance, sees adding dialysis services to its SNFs as a way to strengthen census even amid the changes wrought by the pandemic.
But there’s more to it even than that, Paull told SNN in late March.
“There’s another piece to it as well, what COVID has done to change the health care industry forever,” he said. “And that’s created a larger emphasis on on-site, home-based care. It put that into warp speed, because now everyone sees the benefits of what that means for the patients and for the health care industry. With the increased development of telehealth and everything that has come with that with COVID, the result is that you have a bunch of nursing facilities that are looking to move more services on site, in the nursing facility, as opposed to sending patients out for a service and bringing them back.”
With hospitals increasingly sending patients to the home rather than to the SNF setting, dialysis also provides a chance for SNFs to maximize their reimbursement under the Patient-Driven Payment Model (PDPM), which rewards providers for treating higher-acuity patients — a category that includes those who require dialysis, Josh Rothenberg, the chief operating officer and co-founder of Dialyze Direct noted.
This also makes them more vulnerable to illnesses such as COVID-19, as the Centers for Disease Control and Prevention (CDC) found in summer last year. And for dialysis patients who had to go off-site for their treatment, they had an automatic exposure risk with each trip.
“The fact is no matter how the infection control practices they tried to implement within the nursing home, there was this gap, patients that their lives depended on them going outside to a different facility and mingling with other populations and coming back to the nursing home,” Rothenberg pointed out.
Many SNFs and many states, realizing this, have started to take steps to expand their dialysis offerings. Dialyze Direct in March expanded in the state of Kentucky, after participating in a pilot program for SNF home hemodialysis run by the Bluegrass State’s Department of Health.
This was a six-month program for providers interesting in offering home hemodialysis in SNFs, with each dialysis provider allowed to start in one facility of their choice — though Rothenberg noted that he wasn’t aware of any other company participating in the pilot program. At the end of that time, the state surveyed Dialyze Direct and found it met the benchmarks and quality outcomes it was seeking, though Rothenberg and Paull told SNN they did not know which clinical indicators the state was examining.
Over the course of the pilot, Dialyze Direct worked with six patients; it is now working with a “few dozen” facilities in Kentucky, with a presence in about 125 facilities across its entire footprint: Florida, Illinois, Indiana, Kentucky, Maryland, New Jersey, New York, Ohio, Pennsylvania, Tennessee, and Texas. The company is currently expanding to an additional 170 to 180 facilities, Rothenberg said.
Dialyze Direct is planning this expansion in part because of the demand rising throughout several markets, but also because the Centers for Medicare & Medicaid Services (CMS) is focusing on expanding in-house, staff-assisted home dialysis in the nursing home, Rothenberg said.
One of the clearest indicators of that fact lies in an update to the State Operations Manual — “the Bible of nursing home surveyors,” Rothenberg noted — that CMS made a few years ago. It put an emphasis on the need to educate patients; nursing homes have to educate patients on the ability to have home dialysis on-site, and for any patients who want this service, they must either provide it or move the patient to a facility that can provide it.
For Rothenberg, this is one of the biggest signs of CMS’ focus on providing dialysis on-site.
“One nursing home owner … he told me that pre-PDPM, dialysis was another tool to be able to receive more rehab patients,” he told SNN. “Post-PDPM, it became essential in order to strengthen the financial model of the nursing facilities. Post-COVID, it became almost existential for them to have dialysis on-site.”
Dialyze Direct is pleased to announce the appointment of Stuart Paul as Chief Commercial Officer. Stuart has 25 years of experience in healthcare, with substantial experience managing private and public companies in the renal space.
Previously, Mr. Paul was Corporate Vice President at Abbott Laboratories, a global health care products leader, where he led a $700 million diagnostics business and had responsibility for integrating acquisitions, R&D, manufacturing, and commercial operations. He also served as General Manager at Quest Diagnostics, a global provider of diagnostic testing and information services. Mr. Paul headed Quest’s $1.4 billion East regional division of the USA, and was responsible for managing all laboratory testing, patient services, logistics and commercial operations.
Mr. Paul also held several key senior operating positions at Gambro AB, a $2 billion global dialysis product and services company, and was part of the executive and private equity team that achieved a strategic exit and $4.3 billion sale of the company to Baxter International. While at Gambro, Mr. Paul was responsible for running and scaling a variety of businesses as Region President, including its $550 million of Asia-Pacific and Americas businesses, which he brought to new levels of revenue and profitability. He served as CEO of Rockwell Medical, a publicly traded company that focuses on the development and commercialization of treatments for anemia and chronic kidney disease. Mr. Paul received his MBA from Northwestern University with a concentration in Hospital & Health Services Management and his BA in Chemistry from Duke University.
Mr. Paul’s focus will be on Dialyze Direct’s commercial opportunities, including in the areas of sales and business development, provider relationships, payor relationships, marketing, and enhancing core value propositions. “Stuart’s proven operating experience in high-growth renal care, with a successful track record of executing commercialization strategies will be an instrumental addition to our leadership team, as we bolster Dialyze Direct’s presence around the country, serving our growing patient-base,” said Henry Kauftheil, Dialyze Direct’s Chairman. “We look forward to working closely with Stuart and leveraging his commercial and operational expertise.”
“I initially joined Dialyze Direct in a consultative capacity and quickly realized how well-positioned the company is for both explosive and profitable growth in providing home-based hemodialysis in the SNF and home markets,” said Stuart Paul. “I was impressed how the team managed through two significant waves of Covid-19 in nursing homes during 2020, and still achieved historically high patient census growth and treatment levels for the year. From my prior experience in dialysis companies, I suspected Dialyze Direct’s unique model significantly improves patient outcomes and recovery times, as well as reduces hospitalizations and costs. I am honored to now join Dialyze Direct as Chief Commercial Officer and to guide its commercial expansion as the US market leader in providing a safer, gentler and overall better home-hemodialysis treatment experience for geriatric patients in skilled nursing and home-care environments.”
Leading Kidney Care Company Continues Expansion of its Crucial Services
Dialyze Direct, a leading kidney care company pioneering breakthrough home-based solutions for patients in skilled nursing facilities (SNFs) suffering from kidney disease, announced today the official expansion of its in-SNF home dialysis model to the state of Kentucky. Dialyze Direct now services eleven states nationwide and continues to grow rapidly. The company’s progression is attributed to the high demand for a revitalized dialysis model to serve medically complex geriatric patients, which currently make up 50% of all dialysis patients.
“Over the past few months, we have had the privilege of working closely with the Kentucky Department of Health by participating in their pilot program for SNF home hemodialysis,” said Josh Rothenberg, Dialyze Direct’s Chief Operating Officer. “As the need for increased dialysis options becomes even more evident during these challenging times, we are proud to be among the first providers to support the substantial high-risk geriatric patient population in skilled nursing homes, for whom on-site care is crucial. There is a huge need for our model in Kentucky, and we are excited to meet it with the very best in-facility home dialysis care,” said Rothenberg.
Dialyze Direct provides comprehensive, turn-key home dialysis solutions that allow patients with end-stage renal disease (ESRD) to take advantage of the latest in patient-centric dialysis care. The company’s initial focus in the home dialysis market is on skilled nursing facilities (SNFs), in which many of the most medically challenging subset of dialysis patients reside. Dialyze Direct’s team of physicians, nurses, technicians, renal dietitians and social workers implement personalized plans of care in coordination with a patient’s primary medical team. This gentler treatment plan that can be provided up to five days per week (pursuant to physicians’ orders) consists of meticulously crafted protocols and procedures, that specifically tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations. Dialyze Direct’s care model significantly reduces recovery time following dialysis treatments and eliminates the burden and exposure risks of transportation to dialysis clinics, thereby improving patients’ quality of life.
“We are excited to partner with Dialyze Direct to offer seniors a safe and comfortable place to receive dialysis care,” said Jeremy Bischoff, Executive Director of St. Matthews Care Center. “On-site dialysis at St. Matthews eliminates the need for perpetual quarantine that is often a result of a traditional outpatient settings. We are proud to provide an opportunity for dialysis patients to live fuller lives.”
Dialyze Direct’s expansion into Kentucky is part of its current growth strategy to meet increasing demand for in-SNF dialysis services. Kentucky marks the eleventh state in which Dialyze Direct is active, with expansion slated for several additional states within the next year.
Collaboration is largest adaptation of Dialyze Direct’s staff-assisted home hemodialysis treatment model
Brooklyn, N.Y., May 29, 2019 /PR Newswire/ — Dialyze Direct, LLC, a leader in patient-focused treatment modalities to improve quality of life for people suffering from kidney disease, has entered into a national cooperation agreement with HCR ManorCare, the nation’s leading not-for-profit provider of short and long-term skilled nursing and rehabilitation services. Dialyze Direct will provide staff-assisted in-home hemodialysis services at HCR ManorCare’s ManorCare Health Services skilled nursing facilities (SNF) across multiple states.
At each participating SNF, Dialyze Direct will facilitate comprehensive, turn-key dialysis solutions that will allow patients with end-stage renal disease (ESRD) to receive patient-centric dialysis treatments without leaving the facility. Dialyze Direct’s highly-trained team of physicians, nurses, technicians, renal dietitians and social workers will implement a personalized plan of care in coordination with ManorCare’s skilled nursing and rehab care team. Dialyze Direct staff will perform and manage the complete treatment process and provide all necessary support staff.Additionally, Dialyze Direct will provide ongoing training and education to ManorCare’s staff on best care practices for dialysis patients’ pre and post-dialysis treatment.
“Our world renowned nephrology leadership team deploys the most advanced home dialysis technology to provide treatment that addresses the specific needs of elderly patients, SNFs, hospitals and payors. Dialyze Direct’s patient-centric model of care focuses on significantly improving complex co-morbidities, and provides the best chance to reduce re-hospitilizations” said Josh Rothenberg, Chief Operating Officer of Dialyze Direct. “Partnering with ManorCare enables us to extend our compassionate care model to a wider audience, helping patients improve their quality of life while also lessening the overall cost burden on the healthcare ecosystem.”
Traditional dialysis service requires SNF patients to leave their facility three times a week for hours at a time, disrupting their day-to-day care, meals and rehabilitation plans. Under Dialyze Direct’scare model, ManorCare patients will receive in-home treatment up to five times a week (pursuant to a physicians’ order) at their skilled nursing facility, for approximately two and a half hours. Recovery time for Dialyze Direct’s in-home dialysis treatment is typically around 30 to 60 minutes versus eight to nine hours for traditional dialysis, which can escalate to an average of 21 hours for elderly patients1 . Shorter, more frequent dialysis more closely mimics the operation of healthy kidneys and keeps the amount of toxins and water build-up in the blood to a minimum.
Jaber, B. L., MD, MS, & Lee, Y., MS., et al. (2010). Effect of Daily Hemodialysis on Depressive Symptoms and Postdialysis Recovery Time: Interim Report From the FREEDOM Study (pp. 531-539, Rep.). American Journal of Kidney Diseases.
“For end-stage renal disease patients, dialysis is a life-saving, yet incredibly taxing, medical treatment. With Dialyze Direct’s in-home hemodialysis services, we are looking to change that for residents in our skilled nursing facilities,” said Rami Ubaydi, Vice President and General Manager for HCR
ManorCare. “By eliminating the travel time, logistics, and cost associated with transporting patients to outpatient facilities, while simultaneously improving the quality of dialysis care provided to our patients, our skilled nursing staff will be able to focus on providing quality care and allow our patients to continue their normal social and medical activities.”
According to the Centers for Disease Control and Prevention (CDC), more than 30 million people in the United States (15% of the US population) have chronic kidney disease (CKD), and kidney disease is the ninth leading cause of death in the United States. End-stage renal disease (ESRD), also called kidney failure, is the last stage of CKD. With ESRD, the kidneys are no longer able to filter wastes and excess fluid from the body, causing toxic levels of fluid, electrolytes and wastes to build up in the blood, which makes dialysis or a kidney transplant is necessary. According to the United States Renal Data System (USRDS), more than 726,000 people in the United States are being treated for ESRD, approximately 509,000 of which are receiving dialysis, numbers which are on the rise. The annual Medicare spending to treat ESRD in the U.S. is approximately $35 billion.
About HCR ManorCare
ManorCare Health Services centers are part of HCR ManorCare, a wholly-owned subsidiary of ProMedica, a mission-based, not-for-profit integrated healthcare organization which includes a network of 13 hospitals, 2,600 physicians, a health plan, 400 skilled nursing and rehabilitation centers, memory care communities, outpatient rehabilitation clinics, home health and hospice agencies. Driven by its Mission to improve health and well-being, ProMedica has been nationally recognized for its advocacy programs and efforts to address social determinants of health. For more information about HCR ManorCare, please visit www.hcr-manorcare.com.
About Dialyze Direct
Dialyze Direct is a compassionate, patient-focused company developing treatment modalities to improve quality of life for people suffering from kidney disease by implementing an innovative dialysis care model. By delivering a dialysis method that lowers hospitalizations, infection rates, transportation costs and other patient stressors, Dialyze Direct’s proprietary care model achieves significantly improved outcomes and lowers costs. With a mission to build the next generation kidney care infrastructure, Dialyze Direct works with the world’s best nephrology talent to develop new technology and methods, evolving the treatment options nephrologists have at their disposal.
NxStage Medical, Inc. NXTM recently announced that its subsidiary NxStage Kidney Care is partnering Dialyze Direct for supporting the needs of patients who need on-site skilled-nursing facilities (SNF) for dialysis treatment in Ohio.
In an initiative to reduce transportation costs, re-hospitalization rates and provide dialysis care on site, NxStage will now leverage on its System One platform and Dialyze Direct’s unique model for treating geriatric SNF patients with end stage renal disease (ESRD).
On-site dialysis at SNF is hassle free and counters organizational and operational challenges for dialysis centers and care facilities. NxStage System One helps avoid the hassles of regular transportation for a patient to an off-site dialysis center (almost thrice a week).
Results for on-site dialysis at SNF have been significantly favorable for patients because it has witnessed reductions in both mortality and hospitalizations. Furthermore, patients with higher flexibility are eligible for rehabilitation therapy and social activities.
Notably, U.S.-based Dialyze Direct provides innovative and staff-assisted home hemodialysis services to geriatric patients in skilled nursing facilities (SNF).
Future Trends
Data from Markets And Markets reveal that the global hemodialysis and peritoneal dialysis market is expected to reach a worth of $83.89 billion by 2021, multiplying at a CAGR of 6.0%. Per management, the niche market, especially in the SNF space, has substantial opportunities to improve overall cost of care.
Furthermore, an increased rate of ESRD cases among patients enhances probabilities of NxStage outperformance in the niche space in the near term. In this regard, two major players in the hemodialysis market include DaVita Healthcare Partners, Inc. DVA and Baxter International, Inc. BAX .
NxStage Getting Acquired
Earlier this month, German dialysis provider Fresenius Medical Care FMS signed an agreement to acquire all outstanding shares of NxStage for $30 a share. The transaction has been valued at $2 billion and is subject to close by 2018, on approval of NxStage stockholders and other customary conditions. We note that NxStage has been gaining prominence in the market of late with products like NxStage PureFlow SL Dialysis Preparation System, Nx2me Connected Health and NxStage System One.